Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Drugs of Today (Barcelona, Spain : 1998)|October 10, 2006
RuboxistaurinChristina A Taulien, Scott V JoyThe Annals of Pharmacotherapy|September 15, 2005
Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complicationsScott V Joy, Ann C Scates, Srilaxmi Bearelly, et al.The Diabetes Educator|July 24, 2008
Clinical pearls and strategies to optimize patient outcomesScott V JoyThe Annals of Pharmacotherapy|November 25, 2004
Incretin mimetics as emerging treatments for type 2 diabetesScott V Joy, Philip T Rodgers, Ann C ScatesJournal of Personalized Medicine|January 8, 2015
Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patientsJosephine H Li, Scott V Joy, Susanne B Haga, et al.BMC Health Services Research|January 20, 2012
Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and designAlex H Cho, Ley A Killeya-Jones, Julianne M O'Daniel, et al.Journal of Health Communication|April 7, 2015
Patient beliefs and behaviors about genomic risk for type 2 diabetes: implications for preventionPatrick Gallagher, Heather A King, Susanne B Haga, et al.Pageof 1